Eur Respir J 1994; 7:1616-1621 Copyright ©ERS Journals Ltd 1994
Exogenous surfactant enhances mucociliary clearance in the anaesthetized dog
GT De Sanctis,
RP Tomkiewicz,
BK Rubin,
S Schurch,
and
M King
Therapy with exogenous surfactants is currently used for the treatment of respiratory distress syndrome of the newborn (RDS) and is under investigation for treatments related to adult RDS. However, the possible use of exogenous surfactant as a means of enhancing mucus clearance in other respiratory diseases has not been addressed. We therefore studied the effects of an artificial surfactant (Curosurf) on in vivo tracheal mucus velocity in intubated pentobarbital-anaesthetized dogs. Five dogs were randomly administered, on separate occasions, either vehicle (saline) or 10 mg Curosurf by means of local instillation via a catheter into the right lung. Tracheal mucus was collected by inserting a soft-bristled cytology brush to the level of the carina, and analysed for viscoelasticity by microrheometry. Mucociliary clearability in vivo, tracheal mucus velocity (TMV) in mm.min-1, was determined by bronchoscopic observation of charcoal marker particle transit times. The initial placement of charcoal was at the same level of the lower trachea that mucus was collected from. The effect of ciliary beat frequency was assessed on the frog palate assay by a videoscopic technique. In the dog, TMV was significantly increased after administration of surfactant. The values of TMV in the vehicle- and surfactant-treated dogs were 6.3 +/- 4.0 vs 25.6 +/- 6.5 mm.min-1 (SD), respectively. There were no discernible differences between prevehicle and postvehicle TMV values, and no significant differences in any mucus viscoelastic parameter, as determined by magnetic rheometry.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:

|
 |

|
 |
 
S. T. Ballard, J. C. Parker, and C. R. Hamm
Restoration of Mucociliary Transport in the Fluid-DepletedTrachea by Surface-Active Instillates
Am. J. Respir. Cell Mol. Biol.,
April 1, 2006;
34(4):
500 - 504.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. H. R. F. Rivero, G. Lorenzi-Filho, R. Pazetti, F. B. Jatene, and P. H. N. Saldiva
Effects of Bronchial Transection and Reanastomosis on Mucociliary System
Chest,
May 1, 2001;
119(5):
1510 - 1515.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Banerjee and R. R. Puniyani
Exogenous Surfactant Therapy and Mucus Rheology in Chronic Obstructive Airway Diseases
J Biomater Appl,
January 1, 2000;
14(3):
243 - 272.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Kishioka, M. P. Dorighi, and B. K. Rubin
Perfluorooctyl Bromide (Perflubron) Stimulates Mucin Secretion in the Ferret Trachea
Chest,
March 1, 1999;
115(3):
823 - 828.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. PILEWSKI and R. A. FRIZZELL
Role of CFTR in Airway Disease
Physiol Rev,
January 1, 1999;
79(1):
215 - 255.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Saitoh, H. Okayama, S. Shimura, T. Fushimi, T. Masuda, and K. Shirato
Surfactant Protein A2 Gene Expression by Human Airway Submucosal Gland Cells
Am. J. Respir. Cell Mol. Biol.,
August 1, 1998;
19(2):
202 - 209.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
W. Bernhard, H. P. Haagsman, T. Tschernig, C. F. Poets, A. D. Postle, M. E. van Eijk, and H. von der Hardt
Conductive Airway Surfactant: Surface-tension Function, Biochemical Composition, and Possible Alveolar Origin
Am. J. Respir. Cell Mol. Biol.,
July 1, 1997;
17(1):
41 - 50.
[Abstract]
[Full Text]
|
 |
|
Copyright © 1994 by the European Respiratory Society.
|
|